Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study on oral finerenone for renal function impairment after renal surgery in diabetic patients
jRCT1031250666Recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of finerenone in chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Primary endpoint: Incidence of treatment-related adverse events. Started Apr 2026; status: recruiting.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1031250666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250666.